- DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14(1):1–18.
- Yang Y, Zhao X, Zhu Z, Zhang L. Vascular dementia: A microglia’s perspective. Ageing Res Rev. 2022;101734.
- Karlić R, Chung HR, Lasserre J, Vlahoviček K, Vingron M. Histone modification levels are predictive for gene expression. Proc Natl Acad Sci. 2010;107(7):2926–31.
- Dong X, Weng Z. The correlation between histone modifications and gene expression. Epigenomics. 2013;5(2):113–6.
- Afonso J, Shim WJ, Boden M, Fortes MRS, da Silva Diniz WJ, de Lima AO, et al. Repressive epigenetic mechanisms, such as the H3K27me3 histone modification, were predicted to affect muscle gene expression and its mineral content in Nelore cattle. Biochem Biophys Reports. 2023;33:101420.
- Jhelum P, C Karisetty B, Kumar A, Chakravarty S. Implications of epigenetic mechanisms and their targets in cerebral ischemia models. Curr Neuropharmacol. 2017;15(6):815–30.
- Chakravarty S, Jhelum P, Bhat UA, Rajan WD, Maitra S, Pathak SS, et al. Insights into the epigenetic mechanisms involving histone lysine methylation and demethylation in ischemia induced damage and repair has therapeutic implication. Biochim Biophys Acta (BBA)-Molecular Basis Dis. 2017;1863(1):152–64.
- Schweizer S, Harms C, Lerch H, Flynn J, Hecht J, Yildirim F, et al. Inhibition of histone methyltransferases SUV39H1 and G9a leads to neuroprotection in an in vitro model of cerebral ischemia. J Cereb Blood Flow Metab. 2015;35(10):1640–7.
- Wilson C, Giono LE, Rozes-Salvador V, Fiszbein A, Kornblihtt AR, Caceres A. The histone methyltransferase G9a controls axon growth by targeting the RhoA signaling pathway. Cell Rep. 2020;31(6).
- Nativio R, Lan Y, Donahue G, Sidoli S, Berson A, Srinivasan AR, et al. An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer’s disease. Nat Genet. 2020;52(10):1024–35.
- Lee MY, Lee J, Hyeon SJ, Cho H, Hwang YJ, Shin J, et al. Epigenome signatures landscaped by histone H3K9me3 are associated with the synaptic dysfunction in Alzheimer’s disease. Aging Cell. 2020;19(6):e13153.
- Gupta-Agarwal S, Franklin A V., DeRamus T, Wheelock M, Davis RL, McMahon LL, et al. G9a/GLP histone lysine dimethyltransferase complex activity in the hippocampus and the entorhinal cortex is required for gene activation and silencing during memory consolidation. J Neurosci. 2012;32(16):5440–53.
- Zarrindast MR, Nasehi M, Piri M, Bina P. Anxiety-like behavior induced by histaminergic agents can be prevented by cannabinoidergic WIN55, 212-2 injected into the dorsal hippocampus in mice. Pharmacol Biochem Behav. 2010;94(3):387–96.
- Ooigawa H, Nawashiro H, Fukui S, Otani N, Osumi A, Toyooka T, et al. The fate of Nissl-stained dark neurons following traumatic brain injury in rats: difference between neocortex and hippocampus regarding survival rate. Acta Neuropathol. 2006;112:471–81.
- Farbood Y, Sarkaki A, Khalaj L, Khodagholi F, Badavi M, Ashabi G. Targeting Adenosine Monophosphate-Activated Protein Kinase by Metformin Adjusts Post-Ischemic Hyperemia and Extracellular Neuronal Discharge in Transient Global Cerebral Ischemia. Microcirculation. 2015;22(7):534–41.
- Soltani N, Soltani Z, Khaksari M, Ebrahimi G, Hajmohammmadi M, Iranpour M. The changes of brain edema and neurological outcome, and the probable mechanisms in diffuse traumatic brain injury induced in rats with the history of exercise. Cell Mol Neurobiol. 2020;40(4):555–67.
- Cacabelos R, Teijido O. Epigenetic drug discovery for Alzheimer’s disease. Epigenetics aging Longev. 2018;453–95.
- Shan W, Wu Y, Han X, Chen Q, Wu J. The mechanism of sevoflurane post-treatment alleviating hypoxic-ischemic encephalopathy by affecting histone methyltransferase G9a in rats. Bioengineered. 2021;12(2):9790–805.
- Sharifulina S, Dzreyan V, Guzenko V, Demyanenko S. Histone methyltransferases SUV39H1 and G9a and DNA methyltransferase DNMT1 in penumbra neurons and astrocytes after photothrombotic stroke. Int J Mol Sci. 2021;22(22):12483.
- Sadli N, Ackland ML, De Mel D, Sinclair AJ, Suphioglu C. Effects of zinc and DHA on the epigenetic regulation of human neuronal cells. Cell Physiol Biochem. 2012;29(1–2):87–98.
- Shi R, Zheng C bo, Wang H, Rao Q, Du T, Bai C, et al. Gastrodin alleviates vascular dementia in a 2-VO-vascular dementia rat model by altering amyloid and tau levels. Pharmacology. 2020;105(7–8):386–96.
- Padurariu M, Ciobica A, Lefter R, Serban IL, Stefanescu C, Chirita R. The oxidative stress hypothesis in Alzheimer’s disease. Psychiatr Danub. 2013;25(4):401–9.
- Hudson LC, Bragg DC, Tompkins MB, Meeker RB. Astrocytes and microglia differentially regulate trafficking of lymphocyte subsets across brain endothelial cells. Brain Res. 2005;1058(1–2):148–60.
- Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85(2):296–302.
- Erickson MA, Banks WA. Age-associated changes in the immune system and blood–brain barrier functions. Int J Mol Sci. 2019;20(7):1632.
- Park MJ, Sohrabji F. The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats. J Neuroinflammation. 2016;13:1–14.
- Wang Z, Leng Y, Tsai LK, Leeds P, Chuang DM. Valproic acid attenuates blood–brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab. 2011;31(1):52–7.
- Su L, Liang D, Kuang SY, Dong Q, Han X, Wang Z. Neuroprotective mechanism of TMP269, a selective class IIA histone deacetylase inhibitor, after cerebral ischemia/reperfusion injury. Neural Regen Res. 2020;15(2):277.
- Imakita N, Kitabatake M, Ouji-Sageshima N, Hara A, Morita-Takemura S, Kasahara K, et al. Abrogated Caveolin-1 expression via histone modification enzyme Setdb2 regulates brain edema in a mouse model of influenza-associated encephalopathy. Sci Rep. 2019;9(1):284.
|
